RecruitingPhase 4NCT07094048

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

Studying Multiple myeloma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CHU de Quebec-Universite Laval
Principal Investigator
Dr Julie Côté, MD,FRCPC
CHU de Québec-Université Laval
Intervention
Target trough IgG level of 8-10 g/L(drug)
Enrollment
80 enrolled
Eligibility
18 years · All sexes
Timeline
2026 – 2029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07094048 on ClinicalTrials.gov

Other trials for Multiple myeloma

Additional recruiting or active studies for the same condition.

See all trials for Multiple myeloma →

← Back to all trials